Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -32.91% | $109.64M | 0.85% |
TAIL | -30.29% | $140.49M | 0.59% |
BTAL | -19.56% | $361.41M | 1.43% |
TPMN | -14.16% | $31.54M | 0.65% |
IVOL | -10.58% | $353.94M | 1.02% |
CLIP | -9.53% | $1.50B | 0.07% |
BIL | -8.23% | $45.95B | 0.1356% |
XHLF | -7.44% | $1.46B | 0.03% |
JMST | -6.94% | $3.65B | 0.18% |
FXY | -6.78% | $838.61M | 0.4% |
XONE | -6.33% | $603.24M | 0.03% |
TBLL | -6.23% | $2.46B | 0.08% |
FMF | -6.15% | $153.73M | 0.95% |
GBIL | -5.33% | $6.17B | 0.12% |
SHYM | -4.53% | $322.93M | 0.35% |
GLDM | -4.42% | $14.42B | 0.1% |
BILZ | -4.06% | $876.85M | 0.14% |
FXE | -3.96% | $525.40M | 0.4% |
BOXX | -3.37% | $6.21B | 0.19% |
CTA | -3.36% | $1.05B | 0.76% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EVGO | 0.02% | $532.65M | +68.22% | 0.00% |
LITB | 0.08% | $21.28M | -72.45% | 0.00% |
AGL | -0.11% | $1.06B | -54.30% | 0.00% |
BPT | -0.16% | $13.70M | -73.66% | 0.00% |
FDP | -0.20% | $1.57B | +33.46% | 4.14% |
KGC | 0.24% | $16.92B | +75.38% | 0.89% |
MTA | 0.30% | $262.69M | -2.74% | 0.00% |
EGO | 0.32% | $3.68B | +17.14% | 0.00% |
UNH | 0.33% | $248.87B | -47.37% | 3.06% |
FMS | 0.38% | $16.67B | +26.84% | 2.26% |
VHC | 0.41% | $34.69M | +74.89% | 0.00% |
CRVO | 0.45% | $75.19M | -64.53% | 0.00% |
FARO | 0.46% | $812.11M | +115.84% | 0.00% |
CPSH | -0.46% | $27.45M | +8.62% | 0.00% |
SRRK | 0.47% | $2.92B | +115.29% | 0.00% |
NEXT | 0.48% | $2.01B | +8.30% | 0.00% |
SATS | 0.53% | $6.58B | +33.84% | 0.00% |
SRDX | 0.54% | $400.81M | -17.75% | 0.00% |
LEU | 0.57% | $1.64B | +120.69% | 0.00% |
SCKT | 0.64% | $9.19M | -19.96% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBB | 68.50% | $5.22B | 0.45% |
BBH | 67.85% | $327.42M | 0.35% |
PBE | 63.03% | $214.12M | 0.58% |
FBT | 62.38% | $994.71M | 0.56% |
VHT | 60.31% | $14.92B | 0.09% |
FHLC | 59.86% | $2.42B | 0.084% |
IYH | 59.81% | $2.78B | 0.39% |
PPH | 58.91% | $626.20M | 0.36% |
XLV | 58.51% | $34.49B | 0.09% |
RSPH | 58.25% | $754.08M | 0.4% |
XBI | 58.09% | $4.85B | 0.35% |
IXJ | 57.99% | $3.78B | 0.41% |
IHE | 57.81% | $550.13M | 0.39% |
FXH | 57.27% | $891.82M | 0.62% |
PINK | 56.50% | $131.52M | 0.5% |
XPH | 53.58% | $136.58M | 0.35% |
GNOM | 50.83% | $40.65M | 0.5% |
MOAT | 50.19% | $13.02B | 0.47% |
FTCS | 49.57% | $8.39B | 0.54% |
NOBL | 48.85% | $11.51B | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UUU | -22.44% | $4.93M | +40.20% | 0.00% |
ROOT | -13.05% | $2.18B | +119.56% | 0.00% |
FMTO | -8.41% | $45.74M | -99.96% | 0.00% |
SUP | -8.12% | $16.71M | -84.80% | 0.00% |
SXC | -6.24% | $748.32M | -16.29% | 4.13% |
MKTX | -5.93% | $8.01B | -1.42% | 1.39% |
RLX | -5.86% | $1.77B | -9.30% | 0.49% |
USM | -5.56% | $5.19B | +38.83% | 0.00% |
ATEC | -5.28% | $1.86B | +11.46% | 0.00% |
HEES | -5.00% | $3.52B | +99.54% | 1.15% |
TDS | -4.49% | $3.93B | +68.38% | 0.46% |
PHYS.U | -4.31% | - | - | 0.00% |
AIFU | -3.98% | $9.85M | -95.03% | 0.00% |
TH | -3.94% | $690.70M | -39.27% | 0.00% |
VSA | -3.77% | $7.04M | -49.24% | 0.00% |
HUSA | -3.60% | $9.73M | -55.71% | 0.00% |
GFI | -3.51% | $18.61B | +31.67% | 2.75% |
OR | -3.49% | $4.33B | +41.84% | 0.82% |
STG | -3.42% | $27.05M | -37.35% | 0.00% |
RDUS | -3.13% | $828.01M | +54.12% | 2.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
STPZ | -0.03% | $446.46M | 0.2% |
UNG | -0.14% | $371.83M | 1.06% |
DEFI | -0.44% | $13.07M | 0.94% |
BILS | 0.58% | $3.96B | 0.1356% |
UDN | -0.77% | $137.74M | 0.78% |
GBTC | 0.78% | $19.74B | 1.5% |
UUP | 0.84% | $292.27M | 0.77% |
OILK | -0.88% | $63.21M | 0.69% |
BITB | 0.88% | $4.00B | 0.2% |
IBDQ | 0.89% | $3.08B | 0.1% |
FLMI | 0.89% | $649.76M | 0.3% |
COMT | 0.92% | $606.15M | 0.48% |
SCHO | 0.95% | $10.87B | 0.03% |
BRRR | 0.97% | $637.29M | 0.25% |
FBTC | 1.05% | $20.76B | 0.25% |
PALL | 1.06% | $336.74M | 0.6% |
BITO | 1.07% | $2.49B | 0.95% |
IBIT | 1.07% | $65.44B | 0.25% |
BWX | 1.08% | $1.41B | 0.35% |
ARKB | 1.12% | $5.06B | 0.21% |
MarketWatch
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Yahoo
Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world’s largest pre-college STEM competition in Columbus, Ohio TARRYTOWN, N.Y. and WASHINGTON, May 16, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, won the $100,000 George D. Yancopoulos Innovator Award at the 75th Regenero
SeekingAlpha
Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced melanoma. Read the latest REPL stock analysis here.
Yahoo
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.
Yahoo
While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.
Yahoo
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory damages and $271.2 million dollars in punitive damages TARRYTOWN, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) applauds the jury verdict in the U.S. District Court for the District of Delaware that found that Amgen
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BIIB | 54.49% | $18.13B | -46.23% | 0.00% |
RVTY | 49.21% | $10.66B | -16.65% | 0.31% |
MTD | 48.94% | $23.76B | -25.30% | 0.00% |
IQV | 48.47% | $24.29B | -40.24% | 0.00% |
KRYS | 47.23% | $3.77B | -20.42% | 0.00% |
XYL | 46.03% | $30.81B | -11.26% | 1.17% |
SPB | 45.54% | $1.61B | -30.85% | 2.73% |
AMGN | 45.39% | $146.09B | -13.67% | 3.40% |
TMO | 45.10% | $152.86B | -32.19% | 0.40% |
GEHC | 44.93% | $33.38B | -10.33% | 0.18% |
TECH | 44.75% | $7.56B | -41.77% | 0.49% |
ROIV | 44.74% | $7.68B | -5.70% | 0.00% |
ARW | 44.48% | $6.26B | -7.07% | 0.00% |
LFUS | 44.02% | $5.35B | -13.23% | 1.28% |
IDYA | 43.65% | $1.52B | -58.32% | 0.00% |
VRTX | 43.49% | $111.55B | -1.42% | 0.00% |
CRNX | 43.29% | $2.92B | -39.88% | 0.00% |
AVY | 43.02% | $14.22B | -19.02% | 1.93% |
MFA | 42.87% | $1.01B | -10.64% | 14.30% |
BMRN | 42.74% | $11.17B | -24.30% | 0.00% |
Current Value
$588.231 Year Return
Current Value
$588.231 Year Return
Double maintains 9 strategies that include REGN - Regeneron Pharmaceuticals, Inc.